"Solifenacin Succinate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE.
| Descriptor ID |
D000069464
|
| MeSH Number(s) |
D03.605.687.900 D03.633.100.531.820.594
|
| Concept/Terms |
Solifenacin Succinate- Solifenacin Succinate
- Succinate, Solifenacin
- Quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate
Solifenacin- Solifenacin
- 2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-,1- azabicyclo(2.2.2)oct-3-yl ester, (R-(R*,S*))-
|
Below are MeSH descriptors whose meaning is more general than "Solifenacin Succinate".
Below are MeSH descriptors whose meaning is more specific than "Solifenacin Succinate".
This graph shows the total number of publications written about "Solifenacin Succinate" by people in this website by year, and whether "Solifenacin Succinate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Solifenacin Succinate" by people in Profiles.
-
Diary and patient-reported outcomes in patients with severe overactive bladder switching from tolterodine extended release 4 mg/day to solifenacin treatment: An open-label, flexible-dosing, multicentre study. Clin Drug Investig. 2009; 29(5):305-16.
-
Solifenacin is effective for the treatment of OAB dry patients: a pooled analysis. Eur Urol. 2005 Sep; 48(3):483-7.